Immunocore Files 8-K for Other Events
Ticker: IMCR · Form: 8-K · Filed: Mar 17, 2025 · CIK: 1671927
| Field | Detail |
|---|---|
| Company | Immunocore Holdings PLC (IMCR) |
| Form Type | 8-K |
| Filed Date | Mar 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Other Events
Related Tickers: IMCR
TL;DR
IMCR filed an 8-K on 3/17/25 for other events. Details TBD.
AI Summary
Immunocore Holdings plc filed an 8-K on March 17, 2025, to report other events and financial statements. The filing does not contain specific details about the nature of these events or financial figures within the provided text.
Why It Matters
This filing indicates Immunocore is reporting significant events or financial updates to the SEC, which could impact investors' understanding of the company's current status.
Risk Assessment
Risk Level: low — The filing is a standard procedural report without immediate disclosed financial impact or significant operational changes.
Key Players & Entities
- Immunocore Holdings plc (company) — Registrant
- March 17, 2025 (date) — Date of Report
FAQ
What specific 'Other Events' are being reported by Immunocore Holdings plc in this 8-K filing?
The provided text of the 8-K filing does not specify the nature of the 'Other Events' being reported.
When was this 8-K report filed with the SEC?
This 8-K report was filed on March 17, 2025.
What is the principal executive office address for Immunocore Holdings plc?
The address of the principal executive offices is 92 Park Drive, Milton Park, Abingdon, Oxfordshire, United Kingdom, OX14 4RY.
What is the Commission File Number for Immunocore Holdings plc?
The Commission File Number for Immunocore Holdings plc is 001-39992.
Does the filing provide any financial statements or exhibits?
The filing indicates that 'Financial Statements and Exhibits' are included as Item Information, but the specific content of these is not detailed in the provided text.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 17, 2025 regarding Immunocore Holdings plc (IMCR).